The FDA says state-licensed compounding pharmacies must immediately stop making most compound versions of GLP-1 drugs based on tirzepatide
FIB-4 is recommended as an initial screening test for advanced fibrosis and is calculated using readily available patient information that includes age, AST, ALT, and platelet count
Jumping around these areas distributes the medicine and reduces site exhaustion
There is no established GLP-1 connection
Our Clinic While online care offers convenience for California patients, InjectCo also invites you to visit our Texas clinic for in-person consultations
From reducing inflammation to supporting recovery in chronic and complex conditions, this conversation breaks down the science, the global treatment landscape, and what the future of healing could look like